Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases.

× No keyword cloud information.

37 in total

Review 1. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors: J R Stanley
Journal: J Clin Invest Date: 1989-05 Impact factor: 14.808

2. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities.

Authors: J M Bonifas; A L Rothman; E H Epstein
Journal: Science Date: 1991-11-22 Impact factor: 47.728

3. Mapping of epidermolysis bullosa simplex mutation to chromosome 12.

Authors: M Ryynänen; R G Knowlton; J Uitto
Journal: Am J Hum Genet Date: 1991-11 Impact factor: 11.025

Review 4. Seminars in medicine of the Beth Israel Hospital, Boston. Mutations in collagen genes as a cause of connective-tissue diseases.

Authors: D J Prockop
Journal: N Engl J Med Date: 1992-02-20 Impact factor: 91.245

5. Collagenase in recessive dystrophic epidermolysis bullosa.

Authors: E A Bauer
Journal: Ann N Y Acad Sci Date: 1985 Impact factor: 5.691

6. The new basement membrane antigen recognized by the monoclonal antibody GB3 is a large size glycoprotein: modulation of its expression by retinoic acid.

Authors: P Verrando; A Pisani; J P Ortonne
Journal: Biochim Biophys Acta Date: 1988-07-07

7. Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains.

Authors: D Sawamura; K Li; M L Chu; J Uitto
Journal: J Biol Chem Date: 1991-09-25 Impact factor: 5.157

8. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses.

Authors: P A Coulombe; M E Hutton; A Letai; A Hebert; A S Paller; E Fuchs
Journal: Cell Date: 1991-09-20 Impact factor: 41.582

9. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease.

Authors: R Vassar; P A Coulombe; L Degenstein; K Albers; E Fuchs
Journal: Cell Date: 1991-01-25 Impact factor: 41.582

10. Genomic organization of collagenous domains and chromosomal assignment of human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified squamous epithelium.

Authors: K H Li; D Sawamura; G J Giudice; L A Diaz; M G Mattei; M L Chu; J Uitto
Journal: J Biol Chem Date: 1991-12-15 Impact factor: 5.157

30 in total

1. Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.

Authors: Jon Cogan; Jacqueline Weinstein; Xinyi Wang; Yingping Hou; Sabrina Martin; Andrew P South; David T Woodley; Mei Chen
Journal: Mol Ther Date: 2014-07-23 Impact factor: 11.454

Review 2. Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology.

Authors: R A Eady; M G Dunnill
Journal: Arch Dermatol Res Date: 1994 Impact factor: 3.017

3. Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4).

Authors: L Pulkkinen; D U Kim; J Uitto
Journal: Am J Pathol Date: 1998-01 Impact factor: 4.307

4. Prenatal diagnosis for recessive dystrophic epidermolysis bullosa in 10 families by mutation and haplotype analysis in the type VII collagen gene (COL7A1).

Authors: A M Christiano; S LaForgia; A S Paller; J McGuire; H Shimizu; J Uitto
Journal: Mol Med Date: 1996-01 Impact factor: 6.354

5. Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa.

Authors: B Gatalica; L Pulkkinen; K Li; K Kuokkanen; M Ryynänen; J A McGrath; J Uitto
Journal: Am J Hum Genet Date: 1997-02 Impact factor: 11.025

6. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.

Authors: J L Arbiser; J D Fine; D Murrell; A Paller; S Connors; K Keough; E Marsh; J Folkman
Journal: Mol Med Date: 1998-03 Impact factor: 6.354

7. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

Authors: Jakub Tolar; Akemi Ishida-Yamamoto; Megan Riddle; Ron T McElmurry; Mark Osborn; Lily Xia; Troy Lund; Catherine Slattery; Jouni Uitto; Angela M Christiano; John E Wagner; Bruce R Blazar
Journal: Blood Date: 2008-10-27 Impact factor: 22.113

8. Dominant dystrophic epidermolysis bullosa: identification of a Gly-->Ser substitution in the triple-helical domain of type VII collagen.

Authors: A M Christiano; M Ryynänen; J Uitto
Journal: Proc Natl Acad Sci U S A Date: 1994-04-26 Impact factor: 11.205

9. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

Authors: J C Lapiere; D T Woodley; M G Parente; T Iwasaki; K C Wynn; A M Christiano; J Uitto
Journal: J Clin Invest Date: 1993-10 Impact factor: 14.808

10. Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.

Authors: Xinyi Wang; Pedram Ghasri; Mahsa Amir; Brian Hwang; Yingpin Hou; Michael Khalili; Michael Khilili; Andrew Lin; Douglas Keene; Jouni Uitto; David T Woodley; Mei Chen
Journal: Mol Ther Date: 2013-05-14 Impact factor: 11.454